A Study of V132 in Healthy Older Participants (V132-001)
Public ClinicalTrials.gov record NCT07712575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-Blind, Comparator-Controlled Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of V132 in Healthy Older Participants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.
Study identification
- NCT ID
- NCT07712575
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Interventions
- V132 Formulation 1 Biological
- V132 Formulation 2 Biological
- V132 Formulation 3 Biological
- PREVNAR 20™ Biological
- CAPVAXIVE™ Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2026
- Primary completion
- Jun 20, 2028
- Completion
- Jun 20, 2028
- Last update posted
- Sep 1, 2026
2026 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials ( Site 0006) | Anaheim | California | 92801 | Recruiting |
| Velocity Clinical Research, Hallandale Beach ( Site 0003) | Hallandale | Florida | 33009 | Recruiting |
| Research Centers of America ( Hollywood ) ( Site 0009) | Hollywood | Florida | 33024 | Recruiting |
| QPS-MRA, LLC-Early Phase ( Site 0001) | South Miami | Florida | 33143 | Recruiting |
| Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002) | Springfield | Missouri | 65802 | Recruiting |
| Velocity Clinical Research Lincoln ( Site 0007) | Lincoln | Nebraska | 68510 | Recruiting |
| Velocity Clinical Research, Omaha ( Site 0008) | Omaha | Nebraska | 68134 | Recruiting |
| Remington-Davis, Inc. ( Site 0005) | Columbus | Ohio | 43215 | Recruiting |
| University of Texas Medical Branch ( Site 0004) | League City | Texas | 77573 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07712575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Sep 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07712575 live on ClinicalTrials.gov.